Evidence review
Horse Chestnut for Varicose Veins
Aesculus hippocastanum
The short answer
Good clinical evidenceFor symptoms, yes, to a modest degree. A Cochrane review of 17 short trials found that standardized horse chestnut seed extract eased leg pain, swelling, and itching compared with placebo, and in one trial it reduced swelling about as much as compression stockings. It does not make varicose veins disappear, the trials are old and mostly small, and a later manufacturer trial in more advanced disease did not beat placebo. Use a standardized extract, never raw seeds, and get a vein assessment first.
5 key studies reviewed
Updated October 12, 2026
Key points
-
01
Eases symptoms, not the veins
Trials measured leg pain, swelling, and itching. None showed that varicose veins shrink or disappear, which takes a procedure such as endothermal ablation.
-
02
Consistent short-term benefit
A Cochrane review of 17 trials found less leg pain in six of seven placebo-controlled trials and leg volume about 32 ml lower than placebo across six trials.
-
03
Comparable to stockings in one trial
In 240 patients, the extract and compression stockings reduced leg swelling by similar amounts over 12 weeks. In more advanced disease, only stockings beat placebo.
-
04
Standardized extract only
Trials used seed extracts standardized to escin, classically 50 mg twice daily. Raw conkers, bark, and leaves are poisonous and are not the same product.
-
05
Mild side effects, real cautions
Stomach upset, headache, dizziness, and itching are the usual complaints. Avoid it in pregnancy, with kidney or liver disease, and check first if you take blood thinners.
Horse chestnut seed extract can ease the aching, heaviness, swelling, and itching that often come with varicose veins, but it will not make the veins themselves go away. In a Cochrane review of 17 randomized trials, people taking extracts standardized to escin, the plant’s main active compound, had less leg pain and less leg swelling than people taking a placebo (dummy pill), and side effects were usually mild. One well-known trial found the extract reduced swelling about as much as compression stockings. The caveats are real, though: most trials were small, short, and decades old, several were run by extract makers, and a later trial in more advanced vein disease found no clear benefit over placebo.
Varicose veins are swollen, twisted veins, usually on the legs, caused by faulty valves that let blood pool and stretch the vein. When they cause symptoms such as aching, heavy or swollen legs, itching, or skin changes, doctors call the condition chronic venous insufficiency (CVI). Horse chestnut (Aesculus hippocastanum) is a large park tree whose shiny brown seeds, known as conkers, are poisonous when raw. The medicine is a processed seed extract, developed in Germany in the mid-twentieth century and sold in Europe as a licensed medicine. The European Medicines Agency (EMA) accepts specified extracts as well-established for CVI symptoms, while in the United States horse chestnut is sold as a dietary supplement.
This page goes through the pooled evidence and the key individual trials, including who ran them; how horse chestnut compares with compression stockings and vein procedures; the doses and products tested; and who should avoid it. Nothing here is medical advice. Varicose veins that cause symptoms deserve a proper assessment, usually with an ultrasound scan, and sudden swelling of one leg, a bleeding vein, or a sore that will not heal needs prompt medical care.
02 The trials
Key studies
The trials and reviews that carry the most weight for this question, with the product and dose each one tested. Results apply to the preparation studied.
-
Pittler and Ernst, 2012 (Cochrane)
Systematic review of 17 randomized controlled trials
- Who
- Adults with chronic venous insufficiency; 502 people in the pooled leg-volume analysis
- What and how much
- Oral horse chestnut seed extracts standardized to escin
- How long
- Trials lasted 2 to 16 weeks
Six of seven placebo-controlled trials found significantly less leg pain; leg volume was 32.1 ml lower than placebo (95% CI 13.5 to 50.7) across six trials. Adverse events were usually mild and infrequent. The authors called for larger, definitive trials.
-
Diehm et al., 1996
Randomized, partially blinded, placebo-controlled equivalence trial
- Who
- 240 patients with chronic venous insufficiency, mostly early-stage (Heidelberg, Germany)
- What and how much
- Dry seed extract (Venostasin retard), 50 mg aescin twice daily, versus class II compression stockings or placebo
- How long
- 12 weeks
Lower leg volume fell 43.8 ml with the extract and 46.7 ml with stockings, and rose 9.8 ml with placebo. Both treatments beat placebo and were statistically equivalent; no serious treatment-related events.
-
Diehm and Schmidt, 2000 (reported 2001)
Randomized, multicenter, placebo-controlled; manufacturer study report
- Who
- 355 patients with more advanced chronic venous insufficiency (skin changes or a healed ulcer)
- What and how much
- Venostasin retard, 50 mg aescin twice daily, versus compression stockings or placebo
- How long
- 16 weeks
Leg volume fell 89 ml with stockings and 18 ml with the extract and rose 2 ml with placebo. Stockings beat placebo (p < 0.001); the extract did not (p = 0.115) except in a per-protocol analysis. Reported by a Klinge Pharma employee and a paid consultant.
-
Rehn et al., 1996
Comparative trial with no placebo group; run by the maker of the comparison drug
- Who
- 137 postmenopausal women with chronic venous insufficiency and skin changes
- What and how much
- Horse chestnut extract 600 mg a day versus oxerutins (rutosides) 1,000 mg a day, or 1,000 mg then 500 mg a day
- How long
- 12 weeks of treatment and 6 weeks of follow-up
Leg volume fell in all three groups. The extract performed similarly to the lower-dose oxerutin regimen, while full-dose oxerutins did at least as well. The authors worked for Zyma, which made the oxerutins.
-
Leach et al., 2006
Randomized, triple-blind, placebo-controlled
- Who
- 54 patients with venous leg ulcers in a South Australian community nursing service
- What and how much
- Oral horse chestnut seed extract versus placebo
- How long
- 12 weeks
No significant difference in the number of healed ulcers or in wound size, pain, or exudate. Wound slough fell and dressing changes were fewer with the extract. The trial was small and underpowered.
03 Evidence
What the research shows
Our rating for Horse Chestnut for Varicose Veins, based on the studies below.
The core evidence is a Cochrane review by Pittler and Ernst, last updated in 2012, which included 17 randomized trials of oral horse chestnut seed extracts standardized to escin, lasting between 2 and 16 weeks. Leg pain was measured in seven placebo-controlled trials: six found significantly less pain with the extract, and the seventh found improvement from baseline. In one trial the difference was 42.4 mm on a 100 mm pain scale. Leg volume, a measure of swelling, was measured in seven placebo-controlled trials, and six of them, with 502 people, showed an average of 32.1 ml less volume with the extract than with placebo (95% confidence interval, the range in which the true effect probably lies, 13.5 to 50.7 ml). Some trials also found less itching and smaller calf and ankle circumference. Adverse events were usually mild and infrequent. The reviewers concluded that the extract is an efficacious and safe short-term treatment for CVI, but that several caveats exist and larger, definitive trials are needed, and few new trials of horse chestnut on its own have appeared since.
The trial cited most often is Diehm and colleagues’ comparison with compression stockings (The Lancet 1996). In Heidelberg, 240 patients, most with early CVI, were randomized to an extract providing 50 mg aescin twice daily (Venostasin retard, made by Klinge Pharma), class II compression stockings, or placebo for 12 weeks. Lower leg volume fell 43.8 ml with the extract and 46.7 ml with stockings, while it rose 9.8 ml with placebo. Both treatments beat placebo, and the two were statistically equivalent. There are qualifications: the stockings group was not blinded and took a diuretic (water pill) for the first week to help fit the stockings, a detail reported in a later paper, and in the trial’s own statistical design compression could not be confirmed as the standard against which the extract was judged. The authors concluded that the two were alternative treatments for swelling from CVI.
A second, larger trial by the same team was less favorable. Reported in 2001 by Ottillinger, a consultant paid to write the paper, and Greeske, an employee of Klinge Pharma, it randomized 355 patients with more advanced CVI, with skin changes or a healed leg ulcer, to the same extract, compression stockings, or placebo for 16 weeks. Leg volume fell 89 ml with stockings and 18 ml with the extract, and rose 2 ml with placebo. Stockings were significantly better than placebo, but the extract was not in the main analysis (p = 0.115); it reached significance only when the analysis was limited to the 286 patients who completed the study as planned. Patients with skin changes alone responded better than those with a healed ulcer. Other trials fill in the picture. Rehn and colleagues (Arzneimittel-Forschung 1996), working for Zyma, the maker of a rival vein drug, compared 600 mg a day of horse chestnut extract with oxerutins in 137 postmenopausal women and found leg volume fell with both, with the full oxerutin dose doing at least as well. In 54 people with venous leg ulcers, Leach and colleagues (Journal of Wound Care 2006) found no significant difference in ulcer healing after 12 weeks, although wounds had less slough and needed fewer dressing changes.
Expert bodies place horse chestnut as symptom relief, not as treatment of the veins. EMA’s herbal committee, relying largely on the Cochrane evidence, grants well-established use for the symptoms of CVI, including swollen legs, varicose veins, heaviness, pain, tiredness, itching, tension, and calf cramps. A 2025 review of vein medicines by Gloviczki and colleagues (Journal of Vascular Surgery: Venous and Lymphatic Disorders) graded the leg-volume benefit of horse chestnut as level A evidence, but gave the highest overall marks to micronized purified flavonoid fraction (MPFF), a citrus flavonoid medicine, and to a combination of butcher’s broom extract with hesperidin methyl chalcone and vitamin C; two of its authors disclosed ties to a supplement company. The UK’s National Institute for Health and Care Excellence (NICE) does not include any vein medicine or supplement in its varicose vein guideline. It recommends referring people with symptomatic varicose veins to a vascular service for a duplex ultrasound scan and offering endothermal ablation first, then foam sclerotherapy or surgery, with compression stockings reserved for people who cannot have a procedure.
How the extract works is only partly understood. Escin is a mixture of saponins, and laboratory studies reviewed by Sirtori (Pharmacological Research 2001) suggest it increases the tone of vein walls, reduces leakage of fluid from small blood vessels into surrounding tissue, and dampens inflammation, which fits the trials’ main finding of less swelling. EMA states plainly that the exact mechanism in people is not known. The important open questions are practical ones: whether benefits last beyond a few months, how the extract compares with modern vein procedures, whether it helps people who already have skin damage or ulcers, and how it ranks against other vein medicines in head-to-head trials.
04 In practice
How it was taken in studies
The classic trial dose is an extract providing 50 mg of aescin (escin) twice daily, often as delayed-release tablets or capsules containing about 300 mg of extract each. In 2017 the European Pharmacopoeia changed how these extracts are measured, so EMA now expresses the same dose as 21 mg of protoaescigenin twice daily; the two numbers describe the same product class. EMA says benefit may take at least four weeks, NCCIH considers standardized extracts likely safe for up to 12 weeks, and longer use should be supervised by a doctor. Look for a product that names a standardized seed extract and its escin content, not whole seed powder.
Horse chestnut works best as one part of a plan. The NHS advises keeping to a healthy weight, walking or other regular exercise, raising the legs when resting, avoiding long periods of standing or sitting, not smoking, and moisturizing dry, itchy skin over the veins. If you have been offered compression stockings or a vein procedure, the extract is not a replacement; in the trial of more advanced disease, stockings clearly outperformed it. Horse chestnut gels and creams are sold for heavy legs and bruises, and EMA accepts them as a traditional remedy, but the clinical trials used tablets taken by mouth. Gels should not be applied to broken skin, eyes, or mucous membranes.
If you try an extract, judge it on your symptoms after about a month. Noting how heavy, achy, or swollen your legs feel at the end of the day before you start, and again after four to eight weeks, is a simple way to tell whether it is helping. If nothing has changed by then, there is little reason to continue. Avoid unlabeled “vein support” blends that mix horse chestnut with several other ingredients, because they make it impossible to know which ingredient helped or caused a side effect, and some older liver injury reports involved such blends.
05 Caution
Before you try horse chestnut
Standardized extracts are usually well tolerated in trials of up to 16 weeks. EMA lists stomach and gut complaints, headache, dizziness, itching, and allergic reactions as possible side effects, with frequency unknown, and the Cochrane trials reported adverse events that were usually mild and infrequent. Gels can cause itching or redness. Rarely, horse chestnut products have caused liver injury after four to eight weeks of use; LiverTox describes the cases as usually self-limited. Stop the product and see a doctor for yellow skin or eyes, dark urine, or unusual tiredness.
Raw horse chestnut is a different matter. The seeds, bark, leaves, and flowers contain esculin and saponins and are poisonous when eaten, causing vomiting, diarrhea, muscle twitching, and in severe cases paralysis. Children are most at risk because conkers look like sweet chestnuts. Never make teas or decoctions from fallen seeds, bark, or leaves; the processed extracts used in trials are made to remove the toxic compounds.
EMA does not recommend horse chestnut in pregnancy or breastfeeding, or for anyone under 18, because safety has not been established. MSKCC advises against it with kidney or liver disease. EMA lists no documented drug interactions, but US clinical summaries advise caution with warfarin, other anticoagulants, and antiplatelet drugs, so check with your prescriber or pharmacist if you take a blood thinner.
Some leg problems need medical care rather than a supplement. A swollen, painful calf or sudden swelling of one leg can be a deep vein thrombosis (DVT), a blood clot that needs same-day assessment. A bleeding varicose vein needs urgent help, and a sore on the leg that has not healed within two weeks, hard and painful veins, or darkening or thickening skin need a doctor. Leg swelling can also come from heart or kidney failure, so new swelling should be checked before you treat it as a vein problem.
06 Questions
Frequently Asked Questions
It can ease the symptoms. In a Cochrane review of 17 short trials, standardized horse chestnut seed extract reduced leg pain, swelling, and itching compared with placebo, and EMA accepts specified extracts as well-established for these symptoms. The trials were mostly small and old, and a later trial in more advanced disease found no clear benefit, so expect modest relief rather than a cure.
No. The trials measured leg swelling, pain, and itching, not whether veins shrank or disappeared, and once a vein valve fails the vein does not return to normal on its own. Procedures such as endothermal ablation, foam sclerotherapy, or surgery are what close or remove varicose veins. NICE recommends referral to a vascular service for veins that cause symptoms.
In one 240-patient trial of mostly early vein disease, the extract and compression stockings reduced leg swelling by similar amounts over 12 weeks. But in a later trial of 355 patients with more advanced disease, stockings reduced leg volume by 89 ml and the extract by only 18 ml, which was not clearly better than placebo. The extract may suit people with mild symptoms who cannot tolerate stockings, with a doctor’s agreement.
Trials used a standardized seed extract providing 50 mg of aescin twice daily, which EMA now expresses as 21 mg of protoaescigenin twice daily. EMA says it may take at least four weeks to help. NCCIH considers standardized extracts likely safe for up to 12 weeks, and longer use should be supervised by a doctor. Never use homemade preparations of conkers, bark, or leaves.
There is little trial evidence for them. EMA accepts horse chestnut gels as a traditional remedy for heavy legs and bruises, but the trials behind the well-established rating used tablets taken by mouth. Gels should not go on broken skin, near the eyes, or on mucous membranes, and can occasionally cause itching or redness.
Stomach upset, headache, dizziness, itching, and allergic reactions are the usual complaints, and rare liver injury has been reported after weeks of use. Avoid it in pregnancy or breastfeeding, under 18, and with kidney or liver disease, and check with your prescriber if you take a blood thinner. Raw seeds, bark, and leaves are poisonous and should never be eaten or made into tea.
Butcher’s broom has one good trial in 166 women and is often combined with hesperidin methyl chalcone and vitamin C. Pine bark extract and gotu kola extract have smaller or weaker studies, and ginkgo has only traditional use for heavy legs. Our guide to herbs for varicose veins compares them.
07 References
Sources
These references support the claims on this page. They are not an endorsement of any product. The horse chestnut monograph carries its own full source list.
-
Horse chestnut seed extract for chronic venous insufficiency
Cochrane Database of Systematic Reviews (PubMed 23152216), 2012
Pittler and Ernst: 17 RCTs of escin-standardized extracts; leg pain reduced in six of seven placebo-controlled trials; leg volume WMD 32.1 ml (95% CI 13.49 to 50.72) in six trials with 502 participants; adverse events mild and infrequent; larger definitive trials required.
-
Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency
The Lancet (PubMed 8569363), 1996
Diehm et al.: 240 patients, 50 mg aescin twice daily, class II stockings, or placebo for 12 weeks; leg volume −43.8 ml, −46.7 ml, and +9.8 ml; extract and compression equivalent.
-
Rational therapy of chronic venous insufficiency: chances and limits of the therapeutic use of horse-chestnut seeds extract
BMC Cardiovascular Disorders (PubMed 11747472), 2001
Ottillinger and Greeske (Klinge Pharma): identifies the 1996 trial product as Venostasin retard and its first-week diuretic in the compression group; reports a 355-patient, 16-week trial in CVI grade II/IIIa in which compression (−89 ml) beat placebo but extract (−18 ml) did not (p = 0.115).
-
Comparative clinical efficacy and tolerability of oxerutins and horse chestnut extract in patients with chronic venous insufficiency
Arzneimittel-Forschung (PubMed 8737631), 1996
Rehn et al. (Zyma GmbH): 137 postmenopausal women; horse chestnut extract 600 mg/day versus oxerutins; leg volume reduced in all groups, full-dose oxerutins equivalent or better.
-
Clinical efficacy of horsechestnut seed extract in the treatment of venous ulceration
Journal of Wound Care (PubMed 16620045), 2006
Leach et al.: 54 patients with venous leg ulcers for 12 weeks; no significant difference in ulcer healing; less slough and fewer dressing changes.
-
European Union herbal monograph on Aesculus hippocastanum L., semen (final — revision 1)
European Medicines Agency (EMA/HMPC/628242/2018), 2020
Well-established use for CVI symptoms at 21 mg protoaescigenin twice daily; benefit after at least four weeks; not recommended under 18 or in pregnancy and lactation; gastrointestinal complaints, headache, dizziness, itching, and allergic reactions.
-
Horse chestnut
National Center for Complementary and Integrative Health (NIH), 2025
Possible short-term benefit for CVI; raw plant is toxic; standardized extracts likely safe for up to 12 weeks.
-
Horse chestnut
LiverTox, National Institute of Diabetes and Digestive and Kidney Diseases (NIH), 2018
Rare, usually self-limited liver injury appearing after four to eight weeks; likelihood score D; some cases involved multi-herb products.
-
Horse chestnut
Memorial Sloan Kettering Cancer Center, About Herbs, 2024
Advises against use with compromised kidney or liver function and cautions with anticoagulant and antiplatelet drugs.
-
Varicose veins: diagnosis and management (CG168)
National Institute for Health and Care Excellence (NICE), 2013
Refer symptomatic varicose veins to a vascular service; duplex ultrasound; endothermal ablation first, then foam sclerotherapy or surgery; compression hosiery only if interventional treatment is unsuitable.
-
Varicose veins
NHS, 2026
Symptoms, causes, self-care, when to seek help, and treatments including endothermal ablation, foam sclerotherapy, surgery, and compression stockings.
-
The role of venoactive compounds in the treatment of chronic venous disease
Journal of Vascular Surgery: Venous and Lymphatic Disorders (PubMed 40348378), 2025
Gloviczki et al.: horse chestnut leg-volume effect graded level A; MPFF and Ruscus extract with hesperidin methyl chalcone and vitamin C had the highest overall evidence; two authors disclosed ties to VitasupportMD.
-
Aescin: pharmacology, pharmacokinetics and therapeutic profile
Pharmacological Research (PubMed 11529685), 2001
Sirtori: experimental venotonic, anti-edematous, and anti-inflammatory effects of escin.